肥胖危重症患者肾脏替代治疗的短期与长期结局及15年时间趋势:一项观察性队列研究
该回顾性队列研究纳入2009至2024年入住一个内外科ICU的2192例肥胖(BMI≥30 kg/m2)连续患者,其中295例(13.5%)接受了肾脏替代治疗(KRT)。主要结局90天死亡率在KRT组显著高于非KRT组(49.8% vs 18.9%,p<0.0001),多因素Cox分析证实KRT与死亡率增加独立相关。15年间急性肾损伤(AKI)发生率下降(p<0.001)。作者认为需要前瞻性研究以更好地定义这一高危人群的最佳管理策略。
要点
- 在肥胖危重症患者中,13.5%(295/2192)需要KRT,KRT组90天死亡率为49.8%(95%CI 44.1-55.5),非KRT组为18.9%(95%CI 17.2-20.7),组间差异显著(p<0.0001)。
- 多因素分析证实KRT与肥胖危重症患者死亡率增加独立相关。
- 研究期间(2009-2024年)AKI发生率下降(p<0.001)。
- 作者结论认为需要前瞻性研究以更好地定义该高危人群的最佳管理策略。
适用人群与场景
- 2009至2024年入住一个内外科ICU的所有连续肥胖患者(体重指数≥30 kg/m2)。
诊断标准与关键阈值
- AKI采用KDIGO标准定义。
研究设计与关键结果
- 研究类型为回顾性分析,纳入2192例肥胖危重症患者,其中295例(13.5%)需要KRT。
- 主要结局:90天死亡率KRT组49.8%(95%CI 44.1-55.5)vs 非KRT组18.9%(95%CI 17.2-20.7),p<0.0001。
- 多因素分析证实KRT与死亡率增加独立相关。
- 次要结局:1年死亡率及90天死亡率、AKI和KRT发生率以及SAPS II评分的时间趋势;15年期间AKI发生率下降(p<0.001)。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需要前瞻性研究以更好地定义这一高危人群的最佳管理策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Obesity is a public health challenge and a risk factor for chronic and acute kidney injury (AKI). The impact of kidney replacement therapy (KRT) on mortality in this specific population remains unclear. The objectives of this study were to evaluate the association between KRT and short- and long-term outcomes in patients with obesity, and to analyze trends over time in mortality as well as AKI and KRT incidence.
METHODS: A retrospective analysis was conducted on all consecutive patients with obesity (body mass index ≥ 30 kg/m2) admitted to a medico-surgical intensive care unit from 2009 to 2024. AKI was defined using KDIGO criteria. The primary outcome was 90-day mortality assessed with Kaplan-Meier curves and multivariate Cox analysis. Secondary outcomes included 1-year mortality and time trends assessed on 90-day mortality, AKI, and KRT incidence, as well as SAPS II score.
RESULTS: Among 2,192 patients with obesity included in the study, 295 (13.5%) required KRT. The 90-day mortality was significantly higher in the KRT group compared to the non-KRT group (49.8% (95% CI [44.1-55.5] vs. 18.9% (95% CI [17.2-20.7]), p < 0.0001). Multivariate analysis confirmed that KRT was independently associated with increased mortality. Over the 15-year period, AKI incidence decreased (p < 0.001).
CONCLUSION: Among critically ill obese patients, KRT was independently associated with increased 90-day mortality. These results highlight the need for prospective studies to better define optimal management strategies in this high-risk population.
参考来源
- Monet C, Bouziane J, Pensier J, et al. Short- and long-term outcomes and 15-year time trends of kidney replacement therapy in critically ill patients with obesity: an observational cohort. Intensive Care Med. 2025. PMID: 40586797. doi:10.1007/s00134-025-07990-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。